JDOC vs. BBUS

Last updated Jul 15, 2026

JDOC (Jpmorgan Healthcare Leaders ETF) and BBUS (JPMorgan BetaBuilders U.S. Equity ETF) are both exchange-traded funds - JDOC is a Health & Biotech Equities fund actively managed by JPMorgan, while BBUS is a Large Cap Blend Equities fund tracking the Morningstar US Target Market Exposure Index. JDOC is actively managed, while BBUS is passively managed. Over the past year, JDOC returned 18.76% vs 21.17% for BBUS. At a 0.49 correlation, their price movements are largely independent. JDOC charges 0.65%/yr vs 0.02%/yr for BBUS.

Performance

JDOC vs. BBUS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jpmorgan Healthcare Leaders ETF (JDOC) and JPMorgan BetaBuilders U.S. Equity ETF (BBUS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JDOC achieves a 3.16% return, which is significantly lower than BBUS's 10.50% return.

JDOC

• 1D: -1.51%
• 1M: 3.65%
• 6M: 1.18%
• YTD: 3.16%
• 1Y: 18.76%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BBUS

• 1D: 0.39%
• 1M: 1.72%
• 6M: 8.66%
• YTD: 10.50%
• 1Y: 21.17%
• 3Y*: 20.30%
• 5Y*: 12.67%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

JDOC vs. BBUS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
JDOC Jpmorgan Healthcare Leaders ETF	3.16%	15.36%	-1.04%	7.92%
BBUS JPMorgan BetaBuilders U.S. Equity ETF	10.50%	17.77%	24.89%	13.34%

Correlation

The correlation between JDOC and BBUS is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.37
Correlation (All Time) Calculated using the full available price history since Nov 2, 2023	0.49

The correlation between JDOC and BBUS shifts across timeframes, from 0.37 (1 year) to 0.49 (all time), reflecting how their relationship changes across market environments.

JDOC vs. BBUS - Sectors Allocation Comparison

Sectors	JDOC	BBUS
Healthcare	100.0%	9.1%
Basic Materials	-	1.7%
Communication Services	-	9.8%
Consumer Cyclical	-	9.2%
Consumer Defensive	-	4.5%
Energy	-	3.1%
Financial Services	-	12.0%
Industrials	-	7.7%
Real Estate	-	1.7%
Technology	-	37.5%
Utilities	-	2.7%

Return for Risk

JDOC vs. BBUS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JDOC

JDOC Risk / Return Rank: 45
JDOC Sharpe Ratio Rank: 44
JDOC Sortino Ratio Rank: 51
JDOC Omega Ratio Rank: 42
JDOC Calmar Ratio Rank: 48
JDOC Martin Ratio Rank: 39

BBUS

BBUS Risk / Return Rank: 63
BBUS Sharpe Ratio Rank: 64
BBUS Sortino Ratio Rank: 63
BBUS Omega Ratio Rank: 64
BBUS Calmar Ratio Rank: 58
BBUS Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JDOC vs. BBUS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and JPMorgan BetaBuilders U.S. Equity ETF (BBUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	JDOC	BBUS	Difference
Sharpe ratio: Return per unit of total volatility	1.26	1.69	-0.43
Sortino ratio: Return per unit of downside risk	2.02	2.33	-0.32
Omega ratio: Gain probability vs. loss probability	1.22	1.31	-0.08
Calmar ratio: Return relative to maximum drawdown	1.95	2.31	-0.36
Martin ratio: Return relative to average drawdown	4.93	9.94	-5.01

JDOC vs. BBUS - Sharpe Ratio Comparison

The current JDOC Sharpe Ratio is 1.26, which is comparable to the BBUS Sharpe Ratio of 1.69. The chart below compares the historical Sharpe Ratios of JDOC and BBUS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

JDOC vs. BBUS - Drawdown Comparison

The maximum JDOC drawdown since its inception was -20.87%, smaller than the maximum BBUS drawdown of -35.35%. Use the drawdown chart below to compare losses from any high point for JDOC and BBUS.

Drawdown Indicators

	JDOC	BBUS	Difference
Max Drawdown Largest peak-to-trough decline	-20.87%	-35.35%	+14.48%
Max Drawdown (1Y) Largest decline over 1 year	-9.68%	-9.21%	-0.47%
Max Drawdown (3Y) Largest decline over 3 years	—	-19.01%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-25.46%	—
Current Drawdown Current decline from peak	-3.79%	-0.83%	-2.96%
Average Drawdown Average peak-to-trough decline	-6.81%	-5.40%	-1.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.82%	2.13%	+1.69%

Volatility

JDOC vs. BBUS - Volatility Comparison

Jpmorgan Healthcare Leaders ETF (JDOC) has a higher volatility of 5.41% compared to JPMorgan BetaBuilders U.S. Equity ETF (BBUS) at 3.78%. This indicates that JDOC's price experiences larger fluctuations and is considered to be riskier than BBUS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JDOC	BBUS	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.41%	3.78%	+1.63%
Volatility (6M) Calculated over the trailing 6-month period	11.26%	10.01%	+1.25%
Volatility (1Y) Calculated over the trailing 1-year period	14.95%	12.57%	+2.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.67%	17.15%	-2.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	14.67%	19.54%	-4.87%

JDOC vs. BBUS - Expense Ratio Comparison

JDOC has a 0.65% expense ratio, which is higher than BBUS's 0.02% expense ratio.

Dividends

JDOC vs. BBUS - Dividend Comparison

JDOC's dividend yield for the trailing twelve months is around 0.86%, less than BBUS's 1.01% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
BBUS JPMorgan BetaBuilders U.S. Equity ETF	1.01%	1.07%	1.21%	1.38%	1.57%	1.11%	1.43%	1.37%
JDOC Jpmorgan Healthcare Leaders ETF	0.86%	0.89%	5.57%	0.15%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both JDOC and BBUS in my portfolio?

JDOC and BBUS have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JDOC or BBUS?

JDOC has higher volatility (5.41%) compared to BBUS (3.78%). In terms of maximum drawdown, JDOC dropped -20.87% vs BBUS's -35.35%.

Which ETF is better, JDOC or BBUS?

On 1-year performance, BBUS leads with 21.17% vs 18.76% for JDOC. On fees, BBUS is cheaper at 0.02% per year. On volatility, BBUS has been the lower-risk option at 3.78%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, JDOC or BBUS?

Over the 1-year period, BBUS has performed better with a 21.17% return vs 18.76%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, JDOC or BBUS?

BBUS is cheaper with a 0.02% expense ratio, compared with 0.65% for JDOC.

Which ETF pays a higher dividend yield, JDOC or BBUS?

BBUS has the higher dividend yield at 1.01%, compared with 0.86% for JDOC.

What is the main difference between JDOC and BBUS?

JDOC is categorized as Health & Biotech Equities, while BBUS is Large Cap Blend Equities. Their fees differ too: 0.65% for JDOC and 0.02% for BBUS.

Which has better risk-adjusted returns?

BBUS currently has the higher Sharpe Ratio (1.69 vs 1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.